Health
GC Biopharma Signs Agreement with Catalyst Biosciences for the Acquisition of Rare Disease Pipeline in Hematology
* Entered into an acquisition deal of 3 programs YONGIN, South Korea, Feb. 27, 2023 /PRNewswire/ -- GC Biopharma Corp. (006280.KS), a leading provider of biopharmaceutical products inSouth Korea, announced today that it has signed an Asset Purchase Agreement with Catalyst Biosciences (NASDAQ : ...
2023-02-28 08:53
2229
WAT Med initiates collaborative research study with The Ohio State University to test the effectiveness of EmeTerm - neuromodulation technology to manage nausea and vomiting
VANCOUVER, BC, Feb. 27, 2023 /PRNewswire/ -- The study recruits patients who
suffer from chronic nausea and vomiting. EmeTerm Explore's antiemetic
effectiveness will be tested and measured using subjective responses and
objective physiological data from the patients.
2023-02-28 02:15
1735
Eluminex Biosciences Closes $40+ Million Series B Financing to Continue the Development of Innovative Ophthalmic Assets and Recombinant Human Collagen Technology
SUZHOU, China and SAN FRANCISCO, Feb. 27, 2023 /PRNewswire/ -- Eluminex Biosciences (Suzhou) Limited (Eluminex) officially announced today the closing of a Series B financing of over$40 million (USD). Financing was led by Cenova Capital with additional participation from Guangzhou Yuexiu Industri...
2023-02-28 01:00
1961
Gracell Biotechnologies to Report Fourth Quarter 2022 Financials on Monday, March 13, 2023
SAN DIEGO, Calif., and SUZHOU and SHANGHAI, China, Feb. 27, 2023 /PRNewswire/ -- Gracell Biotechnologies Inc. (NASDAQ: GRCL) ("Gracell" or the "Company"), a global clinical-stage biopharmaceutical company dedicated to developing highly efficacious and affordable cell therapies for the treatment o...
2023-02-27 21:00
1577
The first case of COVID pregnant mother in Guangzhou was successfully delivered by cesarean section and the newborn was in good condition; doctors treat pregnant COVID-19 patient Under Quarantine Protection
The First Case of Successful Delivery of Patient with COVID-19 in Guangzhou GUANGZHOU, China, Feb. 27, 2023 /PRNewswire/ -- "Mother and daughter are safe, the child is 2.85 kilograms." In the early morning ofNovember 1st, director of the Department of Obstetrics and Gynecology, Liang Huichao said...
2023-02-27 17:18
1843
Singleron Biotechnologies and Macrogen Europe announce a strategic alliance
Singleron Biotechnologies and Macrogen Europe are happy to announce their
collaboration to combine their strengths to provide first-class single cell
multi-omics sequencing solutions.
COLOGNE, Germany, Feb. 27, 2023 /PRNewswire/ -- Singleron Biotechnologies
2023-02-27 16:00
1719
Distinguished Acupuncturist in China, Zhaohui Zhang Publishes Paper on Neuromodulation as the Corresponding Author
NANJING, China, Feb. 26, 2023 /PRNewswire/ -- At the beginning of February 2023, Zhaohui Zhang from Jiangsu Provincial People's Hospital received a job offer from the editorial department after the Chinese Lantern Festival. As the corresponding author, he wrote the paper "Auricular Vagal Nerve Sti...
2023-02-27 09:51
1828
China Pharma Holdings Inc. Announces 1-for-10 Reverse Stock Split
HAIKOU, China, Feb. 24, 2023 /PRNewswire/ -- China Pharma Holdings Inc. ("China Pharma" or the "Company") (NYSE American: CPHI) reported that it expects to implement a 1-for-10 reverse stock split on its common stock effectiveMonday, March 6, 2023, with trading to begin on a split-adjusted basis ...
2023-02-25 05:05
5235
Oscotec Announces Topline Results for Phase 2 Trial of Cevidoplenib
* With the efficacy comparable to rival drugs, Oscotec plans to advance to the next step, leaving the door open for partnership PANGYO, South Korea, Feb. 24, 2023 /PRNewswire/ -- Oscotec Inc. announced topline results for Phase 2 trial evaluating the efficacy, safety and tolerability of cevidop...
2023-02-24 22:00
3543
Porton Advanced and Yinjia Biosciences Partner to Enhance CDMO Technology Platform
SUZHOU, China, Feb. 24, 2023 /PRNewswire/ -- On February 20, 2023, Porton Advanced Solutions Ltd. (Porton Advanced) and Yinjia (Shanghai) Biosciences Co., Ltd. (Yinjia Biosciences) announced a strategic partnership in developing core protein raw materials for cell and gene therapy (CGT) and test ...
2023-02-24 20:00
1836
Huichao Liang, An Expert on AIDS Combined with Gynecological Oncology, Receives Excellent Popular Science Worker Award
GUANGZHOU, China, Feb. 24, 2023 /PRNewswire/ -- In 2022, the selection of outstanding popular science workers inGuangzhou was successfully concluded. Dr. Huichao Liang from the Guangzhou Eighth People's Hospital, Guangzhou Medical University was ranked on the list and awarded the title of "Excell...
2023-02-24 16:37
1749
Dr. Lilly Xu Named President of Shanghai ChemPartner
SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- ChemPartner
2023-02-24 05:53
2203
Qilian Received Notification of Deficiency from Nasdaq Related to not timely Filing of Annual Report Form 20-F
JIUQUAN, China, Feb. 23, 2023 /PRNewswire/ -- Qilian International Holding Group Ltd (NASDAQ: QLI) ("Qilian" or the "Company"), aChina-based pharmaceutical and chemical products manufacturer, today announced it has received a notice of non-compliance from Nasdaq Stock Market LLC ("Nasdaq") on Feb...
2023-02-24 05:30
3460
Structo announces a new generation of dental 3D printers powered by MSLA 2.0 for superior Total Cost of Ownership
* ST-01 is a MSLA 2.0-powered 3D printer for high throughput digital production in medium to large dental and orthodontic laboratories. * ST-32 is a semi-automated 3D printer designed for lights-out manufacturing of clear aligner models * New generation of 3D printers are powered by MSLA 2.0...
2023-02-24 00:00
2433
Rayence unveils the first X-ray detector technology utilizing SPAD technology
* Presenting the cutting-edge detector technology, 'SPAD-GS', which is 2.5 times more sensitive to X-rays and 4 times faster than ever * Implemented the world's first X-ray detector using the 'SPAD', digital pixel technology capable of single-photon detection * Being announced and drawing at...
2023-02-23 21:00
2308
Zhongchao Inc. Renews Partnership with Johnson & Johnson (China)
SHANGHAI, Feb. 23, 2023 /PRNewswire/ -- Zhongchao Inc. (NASDAQ: ZCMD) ("Zhongchao" or the "Company"), a platform-based internet technology company offering services to patients with oncology and other major diseases, today announced the renewal of the partnership between Zhongchao Medical Technol...
2023-02-23 21:00
3793
Keymed and Lepu Biopharma Jointly Announce Global Exclusive Licence Agreement with AstraZeneca for CMG901
CHENGDU, China, Feb. 23, 2023 /PRNewswire/ -- Keymed Biosciences Inc., ("Keymed") (Stock Code: 02162 HK) and Lepu Biopharma Co., Ltd, (Stock Code: 02157.HK) today jointly announce a global exclusive licence agreement with AstraZeneca (LSE/STO/Nasdaq: AZN) for CMG901, a potential first-in-class C...
2023-02-23 13:01
1893
150th Anniversary of Dr. Hansen's Discovery of M. leprae Is Opportunity to Examine Past, Present and Future of Leprosy
TOKYO, Feb. 22, 2023 /PRNewswire/ -- The University of Bergen, Norway and Sasakawa Leprosy (Hansen's Disease) Initiative will hold an event inBergen on Feb. 28, 2023, to mark the 150th anniversary of Dr. Gerhard Armauer Hansen's discovery of the leprosy bacillus,M. leprae, in 1873. On the same da...
2023-02-22 22:00
2096
Altos Biologics, a Subsidiary of Alteogen, Completed Patient Enrollment in Global Phase 3 Clinical Trial of Eylea® Biosimilar in Neovascular Age-related Macular Degeneration
* Altos Biologics, a subsidiary of Alteogen, is actively engaged in Eylea® Biosimilar (ALT-L9) clinical development and licensing-out discussions. * Early 2024 projected for Phase 3 completion and product launch in Europe expected after obtaining approval in the first half of 2025. DAEJEON, So...
2023-02-22 22:00
2273
GenScript ProBio and RVAC Medicines Announce Strategic Partnership for GMP Plasmid DNA Manufacturing for mRNA COVID-19 Vaccine Candidate
PISCATAWAY, N.J. and SINGAPORE, Feb. 22, 2023 /PRNewswire/ -- GenScript ProBio, a leading global Contract Development and Manufacturing Organization (CDMO), and RVAC Medicines Pte. Ltd., a biotechnology company focusing on the development and commercialization of messenger RNA (mRNA) therapeu...
2023-02-22 21:00
2523
Week's Top Stories
Most Reposted
Going Global: DCITS Embarks on International Expansion at Singapore Fintech Festival
[Picked up by 313 media titles]
2024-11-12 09:00
DKSH Healthcare and Euris Unveil CRM & MCE Platform "ConnectPlus" to Revolutionize APAC Healthcare Distribution
[Picked up by 292 media titles]
2024-11-13 09:00
Sobot Introduces its All-in-One Solution at GITEX Global 2024
[Picked up by 291 media titles]
2024-11-12 11:00
Ubiqconn Technology to Showcase Latest Marine Solutions at the 2024 International WorkBoat Show in New Orleans
[Picked up by 289 media titles]
2024-11-11 21:00
DND International Eye Hospital: Pioneering SMILE Pro Surgery & Leading the Trend of Refractive Surgery Tourism in Vietnam
[Picked up by 279 media titles]
2024-11-08 20:11
Most Read
Brankas Launches Integrated APAC Open Banking Compliance Solution with ADVANCE.AI's eKYC Solution
2024-11-07 09:00
10154
XtalPi and Sinar Mas Multiartha Launch Strategic Partnership to Revolutionize AI Across Asia-Pacific
2024-11-07 11:34
7512
XTEP's First Mono Store in Malaysia Comes to Puchong
2024-11-07 10:08
6227
